These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

640 related items for PubMed ID: 25002169

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes.
    Maurer MS, Grogan DR, Judge DP, Mundayat R, Packman J, Lombardo I, Quyyumi AA, Aarts J, Falk RH.
    Circ Heart Fail; 2015 May; 8(3):519-26. PubMed ID: 25872787
    [Abstract] [Full Text] [Related]

  • 3. Familial amyloidotic polyneuropathy and transthyretin.
    Nagasaka T.
    Subcell Biochem; 2012 May; 65():565-607. PubMed ID: 23225017
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Recent progress in the understanding and treatment of transthyretin amyloidosis.
    Sekijima Y.
    J Clin Pharm Ther; 2014 Jun; 39(3):225-33. PubMed ID: 24749898
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Specific disruption of transthyretin(105-115) fibrilization using "stabilizing" inhibitors of transthyretin amyloidogenesis.
    Liang Y, Ore MO, Morin S, Wilson DJ.
    Biochemistry; 2012 Apr 24; 51(16):3523-30. PubMed ID: 22482799
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The transthyretin amyloidoses: advances in therapy.
    Dubrey S, Ackermann E, Gillmore J.
    Postgrad Med J; 2015 Aug 24; 91(1078):439-48. PubMed ID: 26048914
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Cerebral amyloid angiopathy with familial transthyretin-derived oculoleptomeningeal amyloidosis].
    Ikeda SI.
    Brain Nerve; 2013 Jul 24; 65(7):831-42. PubMed ID: 23832986
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Trapping the monomer of a non-amyloidogenic variant of transthyretin: exploring its possible use as a therapeutic strategy against transthyretin amyloidogenic diseases.
    Palhano FL, Leme LP, Busnardo RG, Foguel D.
    J Biol Chem; 2009 Jan 16; 284(3):1443-53. PubMed ID: 18984591
    [Abstract] [Full Text] [Related]

  • 17. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
    Taguchi K, Jono H, Kugimiya-Taguchi T, Nagao S, Su Y, Yamasaki K, Mizuguchi M, Maruyama T, Ando Y, Otagiri M.
    Life Sci; 2013 Dec 18; 93(25-26):1017-22. PubMed ID: 24211615
    [Abstract] [Full Text] [Related]

  • 18. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E, Gavazzi A, Merlini G.
    Ital Heart J Suppl; 2002 Jun 18; 3(6):590-7. PubMed ID: 12116807
    [Abstract] [Full Text] [Related]

  • 19. Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants.
    Schwarzman AL, Tsiper M, Wente H, Wang A, Vitek MP, Vasiliev V, Goldgaber D.
    Amyloid; 2004 Mar 18; 11(1):1-9. PubMed ID: 15185492
    [Abstract] [Full Text] [Related]

  • 20. Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis.
    Thenappan T, Fedson S, Rich J, Murks C, Husain A, Pogoriler J, Anderson AS.
    Amyloid; 2014 Jun 18; 21(2):120-3. PubMed ID: 24818650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.